Skip to main content
Contact
Privacy Policy
Term of Use
Purchase Terms
COVID-19 Statement
Company
About
Leadership
Partnering
Contact
Focus
Enzyme Therapeutics
Rare Metabolic Disease
Publications
Programs
Pipeline
Pegzilarginase
AGLE-177
Research Programs
Clinical Trials
Careers
Job Openings
Life at Aeglea
Investors & Media
Patients & Families
Select Page
Investors & Media
Company Overview
Press Releases
Events & Presentations
Stock Information
Stock Quote & Chart
Analyst Coverage
Financials
Quarterly Results
Annual Reports and Proxy
SEC Filings
Governance
Governance Documents
Management
Board of Directors
Committee Composition
Resources
Investor FAQs
Information Request Form
Investor Email Alerts
Investor Contacts
Investors & Media
Company Overview
Press Releases
Events & Presentations
Stock Information
Stock Quote & Chart
Analyst Coverage
Financials
Quarterly Results
Annual Reports and Proxy
SEC Filings
Governance
Governance Documents
Management
Board of Directors
Committee Composition
Resources
Investor FAQs
Information Request Form
Investor Email Alerts
Investor Contacts
Search query
Analyst Coverage
Investors & Media
Company Overview
Press Releases
Events & Presentations
Stock Information
Stock Quote & Chart
Analyst Coverage
Financials
Quarterly Results
Annual Reports and Proxy
SEC Filings
Governance
Governance Documents
Management
Board of Directors
Committee Composition
Resources
Investor FAQs
Information Request Form
Investor Email Alerts
Investor Contacts
Firm
Analyst
Evercore ISI
Josh Schimmer
H.C. Wainwright & Co., LLC
Edward White
Jones Trading
Soumit Roy, Ph.D.
LifeSci Capital, LLC
Sam Slutsky
Piper Sandler
Ted Tenthoff
Wells Fargo Securities
Yanan Zhu, Ph.D.
Aeglea BioTherapeutics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Aeglea BioTherapeutics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Aeglea BioTherapeutics, Inc. or its management. Aeglea BioTherapeutics, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.